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In this study, we compared the cytological, histopathological, and immunohistochemical 
diagnoses of  71 canine cutaneous and subcutaneous masses. Cytological diagnoses 
included 56 tumors (21 mesenchymal, 15 epithelial, 16 round cell, four melanocytic), 13 
infl ammatory reactions, and two cysts. Of  the 21 cytologically diagnosed mesenchymal 
tumors, three were later confi rmed non-tumoral (hematoma, granulation tissue, 
fi broepithelial polyp). Thirteen out of  15 epithelial tumors were correctly diagnosed 
cytologically, whereas two cases were confi rmed to be non-tumoral (fi broepithelial 
polyp, granulation tissue) after histopathological examination. One mast cell tumor 
was later confi rmed as fi brous hyperplasia; diagnoses were correct in other round cell 
tumors. Cytological diagnoses were correct for all melanocytic tumors and cystic lesions. 
Five cases which had been cytologically diagnosed as infl ammatory reactions were 
diagnosed as tumors (lymphoma, papilloma, sebaceous adenoma, and squamous cell 
carcinoma) after histopathological examination. Immunohistochemistry confi rmed the 
histopathological diagnoses of  all epithelial and round cell tumors, while the diagnoses 
of  six mesenchymal tumors were changed after the immunohistochemical examination. 
The total accuracy of  cytology in the diagnosis of  tumoral/non-tumoral masses was 
84.5%, and the accuracy in the determination of  benign/malignant behavior was 
83%. Diagnostic accordance between histopathology and immunohistochemistry was 
86.6%. High success rates obtained with cytological diagnoses prove that cytology is 
a reliable diagnostic tool. The main diagnostic challenge remains with mesenchymal 
tumors and tumors accompanied by infl ammatory reactions. The results suggest that 
immunohistochemistry is fundamental for diagnoses of  most mesenchymal tumors.
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INTRODUCTION
 Cytology is a labor- and cost-effective method that yields results in a very brief  
time compared to histopathology in the diagnosis of  cutaneous and subcutaneous 
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masses [1-3]. However, a proper sample cannot be obtained in many cases, and the 
knowledge and experience of  the examiner directly affect the rate of  accurate diagnosis. 
Since the tissue structure is not observed in cytology, histopathology remains an 
integral part of  the diagnosis [3].
Numerous studies have been carried out to compare the cytological and histopathological 
diagnoses of  both healthy and abnormal structures in humans [4-7] and in animals [8-
12]. The accuracy rate has ranged between 70.5-91% in studies evaluating the reliability 
of  cytology in the diagnosis of  cutaneous and subcutaneous masses [8-10,12,13]. In a 
retrospective study conducted by Simeonov [14], the cytological slides of  300 cutaneous 
and subcutaneous palpable lesions from dogs were compared with histopathological 
slides. The total agreement rate between cytology and histopathology was 88.7%, 
sensitivity was 90.47%, specifi city was 97.22%, positive predictive value was 98.44%, 
and the negative predictive value was 63.63%.
In this study, we compared the cytological diagnoses of  71 cutaneous and subcutaneous 
masses with histopathological and (in some cases) immunohistochemical examination 
results. The predictive value of  cytology for the differentiation of  tumoural/non-
tumoural masses and benign/malignant nature was evaluated.  
MATERIAL AND METHODS 
A total of  71 masses were excised from the skin and subcutis of  dogs, and the cytological, 
histopathological, and (in some cases) immunohistochemical staining results were 
compared. Approval for the study was obtained from the Animal Experiments Local 
Ethics Committee (decree no: B.30.2.ULU.0.8Z.00.00-13). 
Preparation and suitability of cytological slides 
Cytological slides were prepared by using fi ne-needle biopsy, impression smear, or 
scraping techniques [2] and stained with Hemacolor™ (Merck Millipore, Darmstadt, 
Germany). In cases in which a sample could not be collected with fi ne-needle biopsy, 
an impression smear was made on the cut surface of  the masses after surgical removal. 
Scraping technique was used only in masses that yielded very low cellularity with fi ne-
needle aspiration or impression. The suitability of  the cytological slides was assessed 
according to a classifi cation from a previous study [15] and all slides except those of  
poor quality (insuffi cient cell number, thick preparation, etc.) were included. 
Tissue processing for histopathology and immunohistochemistry 
Tissue samples from the masses were fi xed in 10% neutral buffered formalin and were 
processed routinely; 3-5 μm thick sections were stained with hematoxylin-eosin (Merck 
Millipore). Information about the primary antibodies is summarized in Table 1. All 
antibodies were known to cross-react with canine tissues, as confi rmed with previous 
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studies or indicated by the manufacturer. Cases from our archives with confi rmed 
diagnoses were used as the positive control, while negative controls were generated by 
applying PBS instead of  the primary antibody. 









CD3 Dako, M7254 Mouse anti-human F7.2.38 1:25 Overnight
Citrate buffer, 
pH 6, autoclave
CD18 Dr. Peter Moore, - Mouse anti-canine CA16.3C10 1:20 60 min
Citrate buffer, 
pH 6, autoclave
CD20 Thermo Scientifi c, RB-9013-P
Rabbit 
anti-human Polyclonal 1:300 120 min -





anti-human SRA-E5 1:800 Overnight
Citrate buffer, 
pH 6, autoclave
Cytokeratin Dako,  M3515 Mouse anti-human AE1-AE3 1:100 60 min
Citrate buffer, 
pH 6, autoclave
Desmin Dako,  M0760 Mouse anti-human D33 1:100 Overnight
EDTA buffer, 
pH 9, autoclave





Thermo Scientifi c, 
MS-799-PO  
Mouse 




fi lament Dako,  M0762
Mouse 
anti-human 2F11 1:100 60 min
Citrate buffer, 
pH 6, autoclave




actin Dako,  M0874
Mouse 
anti-rabbit Alpha-Sr-1 1:100 Overnight
Citrate buffer, 
pH 6, autoclave
SMA Dako,  M0851 Mouse anti-human 1A4 1:100 Overnight
EDTA buffer, 
pH 9, autoclave
Tryptase Dako, M7052 Mouse anti-human AA1 1:200 45 min
Citrate buffer, 
pH 6, autoclave
Vimentin Dako,  M7020 Mouse anti-cow Vim 3B4 1:200 60 min
Citrate buffer, 
pH 6, autoclave
Examination of the slides 
The cytological slides were examined by one pathologist (VI), histopathological and 
immunohistochemical slides were additionally evaluated by two different pathologists 
with consultation (ITC, AA), who were u ninformed about the cytological diagnosis.
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Comparison of fi ndings
Classifi cation of  epithelial [16], mesenchymal [17-19], and round cell tumors [20,21] 
were made according to previous reports.
Three main criteria were sought while determining the accuracy of  cytology: accuracy 
in diagnosing whether the mass was a tumor or non-tumor, and if  tumoral whether it 
had a benign or malignant character. In cases in which the diagnosis of  a tumor was 
changed to another tumor after the histopathological examination (e.g., diagnosis of  
a trichoblastoma was changed as sebaceous epithelioma), statistical analysis was also 
performed. Finally, the accuracy rate of  histopathological diagnosis was calculated 
after the fi nal diagnoses were determined with immunohistochemical s taining.
Statistics
Sensitivity, specifi city, positive predictive value, negative predictive value, and total 
accuracy rate for cytology were determined as reported previously [22,23] and 
according to the following equations (Table 2):
Sensitivity (true positive rate) = TP/TP+FN; Specifi city (true negative rate) = TN/
TN+FP; Positive predictive value (PPV) = TP/TP+FP; Negative predictive value 
(NPV) = TN/TN+FN; Total accuracy = TP+TN/N .




Tumoral TP FP TP+FP
Non-tumoral FN TN FN+TN
Total TP+FN FP+TN N=TP+TN+FP+FN
*TP: True positive, FP: False positive, FN: False negative, TN: True negative, N: Total case number. 
Sensitivity (true positive rate) = TP/TP+FN; Specifi city (true negative rate) = TN/TN+FP; Positive 
predictive value (PPV) = TP/TP+FP; Negative predictive value (NPV) = TN/TN+FN; Total accuracy 
= TP+TN/N.
RESULTS
Comparison of cytological and histopathological fi ndings 
Cytological examination of  71 masses revealed that 56 masses were tumoral (21 
mesenchymal, 15 epithelial, 16 round cell, four melanocytic), 13 were infl ammatory, 
and two were cystic lesions. Histopathological examination revealed 55 tumors (17 
mesenchymal, 17 epithelial, 17 round cell, four melanocytic), eight infl ammatory 
reactions, six tumor-like/hyperplastic changes, and two cystic lesions (Tables 3-5). The 
accuracy rate of  cytological diagnosis in determining tumors and non-tumors were as 
follows: Sensitivity (true positive rate)=90.9 %, specifi city (true negative rate)=62.5 
%, positive predictive value=89.2 %, negative predictive value=66.6 %, total accuracy 
=84.5 % (Table 6). 
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Table 3. Comparison of  the cytological, histopathological, and immunohistochemical diagnoses 















Fibroma (1) Rhabdomyoma (1)
S100+, SRCA+, Vim+ 
CD31-, Des-, Mel-A-, 
Neu-, CK-, SMA-
Lipoma (6) Lipoma (6) ---




CD31-, Des-, Mel-A-, 
Neu-, CK-, SMA-, 
SRCA-
Malignant fi brous 
histiocytoma (2)











Perineuroma (1) Perineuroma (1)
S100+, Vim+ 
CD31-, Des-, Mel-A-, 
Neu-, CK-, SMA-, 
SRCA-






S100-, CD31-, Des-, 
Mel-A-, Neu-, CK-, 
SMA-, SRCA-





CD31-, Des-, Mel-A-, 





Malignant fi brous 
histiocytoma (1)
Malignant fi brous 
histiocytoma (1)
CD204+, Vim+ 
CD3-, CD18-, CD20-, 
E-Cad-, Tryp-





S100-, CD31-, Des-, 






SMA+, SRCA+, Vim+ 







S100-, CD31-, Des-, 
Mel-A-, Neu-, CK-, 
SMA-, SRCA-
Fibroepithelial polyp (1) ---
*Immunohistochemical staining was not performed in “---” marked cases. Incompatible diagnoses are 
written with bold characters. **SRCA: Sarcomeric actin, Vim: Vimentin, Des: Desmin, Mel-A: Melan-A, 
Neu: Neurofi lament, CK: Cytokeratin, SMA: Smooth muscle actin, E-Cad: E-Cadherin, Tryp: Tryptase.
***PNST: Peripheral nerve sheath tumor 
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Table 4. Comparison of  the cytological, histopathological, and immunohistochemical 

























S100-, CD31-, Des-, 
Mel-A-, Neu-, CK-, SMA-, 
SRCA-


























Sebaceous adenoma (1) Sebaceous adenoma (1) Sebaceous adenoma (1)
CK+
Vim-
*Immunohistochemical staining was not performed in “---” marked cases. Incompatible diagnoses are 
written with bold characters.
**CK: Cytokeratin, Vim: Vimentin, Des: Desmin, Mel-A: Melan-A, Neu: Neurofi lament, SMA: Smooth 
muscle actin, SRCA: Sarcomeric actin
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Table 5. Comparison of  the cytological, histopathological, and immunohistochemical 
diagnoses of  16 round cell tumours, 4 melanocytic tumours, 13 infl ammatory conditions, and 
2 cystic lesions. Classifi cation of  the cases is based on cytological diagnosis.






Histiocytoma (3) Histiocytoma (3) Histiocytoma (3)
CD18+ 
CD3-, CD20-, CD204-, 
E-Cad-, Tryp-
Histiocytoma (1) Histiocytoma (1) Histiocytoma (1)
CD18+, E-Cad+
CD3-, CD20-, CD204-, 
Tryp-




Lymphoma (1) Lymphoma (1) Lymphoma (1) CD3+, CD18+CD20-, E-Cad-, Tryp-
Mastocytoma (8)



















CD3-, CD20-, E-Cad-, 
Tryp-
Infl ammatory reaction 
(12)
Infl ammatory reaction 
(7) ---




















cyst (2) Epidermoid cyst (2) ---
*Immunohistochemical staining was not performed in “---” marked cases. Incompatible diagnoses are 
written with bold characters. 
** E-Cad: E-Cadherin, Tryp: Tryptase, Vim: Vimentin, CK: Cytokeratin
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Tumoral 50 (TP) 6 (FP) 56
Non-tumoral 5 (FN) 10 (TN) 15
Total 55 16 71 (N)
*TP: True positive, FP: False positive, FN: False negative, TN: True negative, N: Total case number
Accuracy rate: 84.5% (TP+TN/N)
Histopathological examination revealed a papilloma which was cytologically diagnosed 
as infl ammatory reaction. Two trichoblastoma diagnoses in cytology was changed 
to sebaceous epithelioma and perivascular wall tumor, and in one case, malignant 
fi brous histiocytoma diagnosis in cytology was changed as trichoepithelioma 
after histopathological examination. In two cases, in which infl ammatory reaction 
diagnosis was made cytologically, squamous cell carcinoma diagnoses were made 
Figure 1. Sebaceous adenocarcinoma (a) Glandular epithelial cells showing adenoid formation 
(arrows) and mild anisokaryosis with abundant vacuoles and indistinct cytoplasmic borders, 
Hemacolor, x400. (b) Atypical epithelial cells having ample mitotic fi gures and vacuolated 
cytoplasms, Haematoxylin-Eosin, x200. (c) Cytokeratin positivity and (d) vimentin positivity 
in tumoral cells, avidin-biotin complex method, DAB chromogen, x200.
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after histopathological examination. A diagnosis of  perianal gland adenoma was 
changed to perianal gland epithelioma histopathologically. In one case, cytologically, 
an infl ammatory reaction was diagnosed due to the existence of  neutrophils, but this 
diagnosis was changed as sebaceous hyperplasia/adenoma after histopathological 
examination. One case (Fig. 1a) that was cytologically diagnosed as carcinoma was 
histopathologically diagnosed as sebaceous adenocarcinoma (Fig. 1b).
A melanocytoma diagnosis in cytology was changed as malignant melanoma after 
histopathological examination. Another malignant melanoma diagnosis by cytology 
was compatible with histopathological diagnosis.
Diagnoses of  benign mesenchymal tumor, malignant mesenchymal tumor, 
and trichoblastoma in cytology were changed as perivascular wall tumor after 
histopathology. In two cases, benign mesenchymal tumor diagnoses were hemangioma 
and perineuroma after histopathology. Hemangiopericytoma diagnosis in cytology 
was changed as fi broma after histopathology. Malignant mesenchymal tumor 
diagnosis in cytology was malignant fi brous histiocytoma after histopathology. 
Cytologically malignant mesenchymal tumor diagnosis in a case (Fig. 2a) was changed 
as undifferentiated sarcoma at histopathology (Fig. 2b). Myxoma diagnosis in the 
Figure 2. Haemangiopericytoma. (a) Atypical spindle cells with eosinophilic matrix (arrows), 
Hemacolor, x200. (b) Spindle cell proliferation around vessels, Haematoxylin-Eosin, x200. (c) 
SRCA positivity and (d) SMA positivity in tumoral cells, avidin-biotin complex method, DAB 
chromogen, x400.
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cytological examination (Fig. 3a) was changed as myxoid peripheral nerve sheath 
tumor (PNST) after histopathology (Fig. 3b).
In a case which was cytologically diagnosed as mastocytoma, histopathological diagnosis 
was made as fi brous hyperplasia due to intense fi brous tissue hyperplasia with scattered 
mast cells in the dermis. Cytological and histopathological diagnoses were compatible 
in four histiocytomas (Figs. 4a and 4b) and three histiocytic sarcomas (Figs. 5a and 
5b). In a case diagnosed as lymphoma, cytological and histopathological diagnoses 
were compatible. In another case, cytology revealed numerous yeasts resulting in a 
diagnosis of  Malassezia dermatitis, but the fi nal diagnosis after histopathology was 
epitheliotrophic lymphoma associated with Malassezia. Malignant fi brous histiocytoma 
diagnosis in cytology (Fig. 6a) was changed as malignant histiocytosis in histopathology 
(Fig. 6b).
Seven infl ammatory reaction diagnoses cytologically were compatible with 
histopathological diagnoses. In a case, cytologically numerous atypical large epithelial 
cells with abundant cytoplasmic vacuoles were observed, and adenocarcinoma was 
Figure 3. Myxoid peripheral nerve sheath tumor (PNST). (a) Spindle cells above eosinophilic 
matrix (arrows), Hemacolor, x200. (b) Round cell clusters formed by spindle cell proliferation 
consisting of  lightly basophilic mucinous material, Haematoxylin-Eosin, x200. (c) S100 
positivity and (d) Vimentin positivity in tumoral cells, avidin-biotin complex method, DAB 
chromogen, x400. 
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diagnosed, but after histopathological examination, diagnosis was changed as chronic 
granulomatous reaction.
Cytologically, a malignant mesenchymal tumor was diagnosed in a case, but the 
diagnosis was changed as fi broepithelial polyp by histopathology. In another case, 
cytologically a fi bropapilloma was diagnosed, but histopathologically fi broepithelial 
polyp was diagnosed. In one case cytological diagnosis of  hemangiosarcoma was 
changed as hematoma in histopathology. In the cytological examination of  a case, 
benign mesenchymal tumour was diagnosed, however histopathologically, granulation 
tissue formation was diagnosed. In a case, cytological infl ammatory reaction diagnosis 
was changed as sebaceous hyperplasia in histopathology.
In two cases, epidermal inclusion cysts were cytologically diagnosed and these 
diagnoses were changed as epidermoid cyst by histopathology. 
Figure 4. Histiocytoma. (a) Round-oval cells having prominent grey cytoplasm, Hemacolor, 
x200. (b) Numerous histiocytes proliferations in the dermis, Haematoxylin-Eosin, x400. (c) 
CD18 positivity in tumoral cells and (d) E-cadherin positivity in the borders of  tumoral cells, 
avidin-biotin complex method, DAB chromogen, x400. 
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Comparison of histopathological and immunohistochemical fi ndings
All tumoral cases except melanocytic tumors and lipomas were stained 
immunohistochemically. The histopathological diagnoses were confi rmed in 40 
tumors, but changed in six cases, all of  which were of  mesenchymal descent. 
Cytokeratin and vimentin immunohistochemical stainings were used for all epithelial 
tumors. All cases were positive for cytokeratin and negative for vimentin except one 
sebaceous adenocarcinoma case, where both cytokeratin and vimentin were positively 
stained (Figs. 1c and 1d). Histopathological and immunohistochemical diagnoses were 
compatible for all epithelial tumors. 
CD31, CD204, cytokeratin, desmin, Melan-A, neurofi lament, S100, sarcomeric 
actin, smooth muscle actin, and vimentin antibodies were used for the diagnosis of  
mesenchymal tumors, except two hemangioma cases where only CD31 positivity was 
considered suffi cient due to the typical histopathological appearance. All histiocytic 
sarcomas were positive for CD18, CD204 (Fig. 5c), E-cadherin (Fig. 5d) and vimentin, 
but negative for CD3, CD20, and tryptase. Final diagnosis of  these cases was made as 
histiocytic sarcoma. 
Figure 5. Histiocytic sarcoma. (a) Round-oval cells showing prominent anisokaryosis, 
Hemacolor, x200. (b) Round-oval and spindle-shaped atypical cells, Haematoxylin-Eosin, 
x400. (c) CD204 positivity in tumoral cells and (d) E-cadherin positivity of  the borders of  
tumoral cells, avidin-biotin complex method, DAB chromogen, x400.
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All mesenchymal tumors were negative for cytokeratin and positive for vimentin. In one 
case with a histopathological diagnosis of  fi broma, positivity was observed for S100, 
sarcomeric actin, and vimentin, and the fi nal diagnosis was made as rhabdomyoma. 
One of  the three histopathologically diagnosed perivascular wall tumors was positive 
for S100 and vimentin, and the diagnosis was changed as hemangiopericytoma. 
Two other perivascular wall tumors were positive only for vimentin, therefore the 
diagnosis was redefi ned as undifferentiated sarcoma. In one case of  undifferentiated 
sarcoma, tumor cells stained with anti-sarcomeric actin (Fig. 2c), SMA (Fig. 2d), and 
vimentin, so the fi nal diagnosis was hemangiopericytoma. In another case which was 
histopathologically diagnosed as haemangioma, tumor cells were negative for CD31 
and all other mesenchymal markers except vimentin, and the fi nal diagnosis was 
defi ned as benign mesenchymal tumor.
The antibodies used for the immunohistochemical diagnosis of  round cell tumors 
were as follows: tryptase for mast cell tumours; CD3, CD18, CD20, E-cadherin, and 
tryptase for lymphomas; and CD3, CD18, CD20, CD204, E-cadherin, and vimentin 
for histiocytic tumors. All seven mastocytoma cases were confi rmed after positive 
Figure 6. Malignant histiocytosis. (a) Infl ammatory cells, large histiocytes, and multinucleated 
giant cell (arrow), Hemacolor, x200. (b) Pleomorphic histiocytes with distinct nucleolus, 
rounded nuclei, and multiple nuclei observed as clusters, Haematoxylin-Eosin, x200. (c) CD204 
and (d) vimentin positive histiocytes, avidin-biotin complex method, DAB chromogen, x400.
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immunostaining with tryptase. CD18 positivity (Fig. 4c) together with CD3, CD20, 
CD204, and tryptase negativity were observed in all histiocytoma cases. E-cadherin 
positivity (Fig. 4d) was seen only in one histiocytoma case and, therefore, a Langerhans 
cell origin was suspected. In a malignant histiocytosis case, CD18, CD204 (Fig. 6c), 
E-cadherin and vimentin (Fig. 6d) positivity were observed and the diagnosis was 
confi rmed.
One histopathologically diagnosed lymphoma case was positive for CD3 and CD18, 
but negative for CD20, E-cadherin, and tryptase, and a fi nal diagnosis was made as 
T-cell lymphoma. The other lymphoma case was positive for CD18, but negative 
for CD3, CD20, E-cadherin and tryptase, and the fi nal diagnosis in this case was 
considered as null-lymphoma. 
Compatibility rate of  histopathological and immunohistochemical diagnoses were 
found as 86.6 %.  All control tissues were positive in terms of  the relative cell 
components. Additionally, some tumoral cases were used as self-control tissue for 
normal components on the slides. All negative control slides were negative for used 
antibodies. 
Accuracy of cytology in characterizing benign/malignant nature
In order to determine the accuracy of  cytological diagnosis in defi ning benignancy/
malignancy, cytological and immunohistochemical staining results were compared 
because benign/malignant differentiation of  some cases could be possible after 
immunohistochemistry. Non-tumoral lesions were considered as benign formations. 
The values were calculated as follows: sensitivity (true positive rate) = 76 %, specifi city 
(true negative rate) = 86.9 %, positive predictive value = 76 %, negative predictive 
value = 86.9 %, total accuracy rate = 83 % (Table 7).
Table 7. Number of  cases for benign-malignant comparison
Cytological diagnosis
Histopathological diagnosis*
Malignant Benign or non-tumoral Total
Malignant 19 (TP) 6 (FP) 25
Benign or non-tumoral 6 (FN) 40 (TN) 46
Total 25 46 71 (N)
*TP: True positive, FP: False positive, FN: False negative, TN: True negative
Accuracy rate: 83.1% (TP+TN/N)
Accuracy of cytology in the specifi c-general diagnosis of tumors
For the evaluation of  the accuracy rate for specifi c and general diagnosis between 
cytology and histopathology, statistical analysis was performed. Specifi c diagnosis such 
as hemangioma, lipoma, trichoblastoma, mastocytoma etc. and general diagnosis such 
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as benign mesenchymal tumor, malignant mesenchymal tumor, carcinoma etc. were 
compared. All changing diagnosis were evaluated in this statistical comparison without 
considering diagnostic accordance for the character of  the tumor. The values were 
calculated as follows: sensitivity (true positive rate) = 73.4 %, specifi city (true negative 
rate) = 40.9 %, positive predictive value = 70.5 %, negative predictive value = 40.9 %, 
total accuracy rate = 63.3 % (Table 8).
Table 8. Number of  cases for specifi c and general diagnoses*
Cytological diagnosis
Histopathological diagnosis
Specifi c diagnosis General diagnosis Total
Specifi c diagnosis 36 (TP) 13 (FP) 51
General diagnosis 13 (FN) 9 (TN) 22
Total 49 22  71
TP: True positive, FP: False positive, FN: False negative, TN: True negative
* Specifi c diagnosis: Exact diagnosis such as squamous cell carcinoma or haemangiopericytoma
   General diagnosis. Broad diagnosis such as benign mesenchymal tumor or carcinoma
Accuracy rate: 63.4% (TP+TN/N)
DISCUSSION
 Cytology is a quick and reliable tool in most pathology laboratories. In dogs, 
the accuracy of  cytological diagnoses was tested in various studies yielding different 
accuracy rates [1,10,12-14]. Cohen et al. [10] evaluated 269 masses cytologically and 
histopathologically and 63.2% accuracy rate was calculated when insuffi cient samples 
were excluded. Ghisleni et al. [12] have compared the cytological and histopathological 
fi ndings of  292 palpable cutaneous and subcutaneous masses in 242 dogs and 50 
cats between 1999-2003. As a result, 90.9% of  the cases showed agreement between 
cytological diagnosis and histopathological diagnosis. In another retrospective study 
conducted by Simeonov [14], the cytological preparations of  300 cutaneous and 
subcutaneous palpable lesions of  dogs were compared with histopathological slides 
and total agreement rate between cytology and histopathology was 88.7%. 
It should be noted that changes in the nomenclature of  tumors in time and failure 
to use standardized criteria may lead to controversies in histological diagnosis, 
which naturally affects compliance with cytological diagnosis [24-26]. In our study, 
histopathological diagnoses were made according to the previous tumor classifi cations 
and additional immunohistochemical stainings were performed in order to eliminate 
the above mentioned disputes.
In our study, a mesenchymal malignant tumor, a haemangiosarcoma, and an 
adenocarcinoma were misdiagnosed in cytology and diagnoses were changed as 
fi broepithelial polyp, organizing haematoma and chronic granulomatous infl ammation, 
respectively. It is diffi cult to distinguish well-differentiated haemangiosarcomas from 
benign haemangiomas and/or haematomas (which form reactive fi broblasts in the 
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wall), and histological examination is often necessary for the defi nitive diagnosis [27]. 
It has been reported that infl ammation can induce dysplastic changes and such cases 
can be misinterpreted as a tumor [2]. Large epithelioid macrophages and proliferating 
fi broblasts are commonly observed in infl ammatory lesions and these cells can be 
similar to malignant tumor cells. Also squamous cells, fi broblasts, and transitional 
epithelial cells can exhibit marked anisonucleosis, distinct nucleoli, mitotic fi gures, and 
variations in nucleus:cytoplasm ratio, features all of  which can be confused with tumor 
cell features [2,28]. 
In the study of  Simeonov [14], 19 cases with a diagnosis of  infl ammation in cytology 
were diagnosed as tumor in histopathology. It should be remembered that infl ammation 
can coexist in tumors [29]. In our study, cytological diagnoses of  fi ve infl ammatory 
reactions were changed as a papilloma, a sebaceous adenoma, a sebaceous hyperplasia, 
and two squamous cell carcinomas after histopathology. This demonstrates the 
importance of  careful examination of  tumors with concurrent infl ammatory reaction. 
Origin of  melanocytic tumors was determined accurately in cytology by observing 
dense melanin pigmentation. In our study, one case of  melanocytoma diagnosis 
in cytology was changed as malignant melanoma in histopathology. The reason of  
this incompatibility was diffi culty of  nuclear malignancy evaluation due to dense 
pigmentation. In the study of  Simeonov [14], all melanocytic tumor diagnoses in 
cytology were confi rmed with histopathology. In that study, tumor character was not 
evaluated in cytology, but all cases were diagnosed as benign in histopathology. In our 
study, malignancy could be evaluated in other cases due to the low pigmentation of  
cells in cytology.
We did not subclassify mesenchymal tumors cytologically in most cases in our 
study. Instead, they were classifi ed as benign or malignant mesenchymal tumors in 
nine cases, and these diagnoses were consistent with the fi nal diagnoses. Similarly, 
Ghisleni et al. [12] reported that cytomorphology was inadequate for determining 
the cell type in 45 of  69 (67.2%) mesenchymal tumors and these cases were defi ned 
as sarcoma. In Simeonov’s study [14], 33 of  the mesenchymal tumors could not be 
subclassifi ed, of  which 25 were later identifi ed as fi brosarcoma, fi ve as liposarcoma, 
two as osteosarcoma, and one as myxosarcoma.
Mesenchymal tumors comprise 8-15% of  canine cutaneous and subcutaneous tumors 
and are formed mostly by spindle-shaped cells [30]. Differential diagnosis of  these 
tumors is diffi cult due to similar morphological patterns [17,20]. Immunohistochemically 
vimentin expression is suggestive of  a mesenchymal origin [31]. In accordance with 
this, all mesenchymal tumors were vimentin positive in our study. Even with additional 
immunohistochemical diagnostic markers, a mesenchymal tumor origin may not always 
be determined [19,32]. An immunohistochemical panel for defi nitive differentiation of  
mesenchymal tumors has not been defi ned yet [33]. Due to this ambiguity, sometimes 
these tumors are named as spindle cell tumors of  the soft tissue [31,34,35]. In our 
study, an exact diagnosis could not be reached in two mesenchymal tumors and these 
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tumors were diagnosed as undifferentiated sarcoma. Histopathologic diagnosis of  two 
perivascular wall tumors were undifferentiated sarcoma after immunohistochemistry 
due to vimentin positivity alone. Additionally, a case of  haemangioma was negative for 
all markers except vimentin and the fi nal diagnosis was changed as benign mesenchymal 
tumor depending on the histopathological pattern. 
In our study, vimentin and S100 positivity were observed in cases histopathologically 
diagnosed as myxoid PNST (Figs. 3c and 3d) and perineuroma. GFAP and S100 are 
suggested as useful markers for the diagnosis of  PNSTs [20]. Peripheral nerve sheath 
tumors originate from Schwann cells, modifi ed Schwann cells, fi broblasts or perineural 
cells [36]. Haemangiopericytoma should be primarily considered in the differential 
diagnosis of  PNSTs. Especially, the perivascular spiral pattern is characteristic for 
haemangiopericytomas. These patterns have also been observed in PNSTs especially 
around collagen fi bres instead of  capillaries [31]. Similarly, we observed these patterns 
around nerve fascicles which included fi ne collagen fi bres in the case of  perineuroma 
and these areas were positive for S100. Although high positivity rates have been 
reported with neurofi lament [37], in our study neurofi lament immunostaining was 
negative in all cases.
Chijiwa et al. [32] reported that α-SMA may be useful for differentiation of  PNSTs 
and hemangiopericytomas. They observed that 17 PNSTs were negative and fi ve 
hemangiopericytomas were positive for α-SMA. In another study which involved 
cases of  hemangiopericytoma, leiomyosarcoma, and hemangiosarcoma, α-SMA was 
positive in six of  18 hemangiopericytomas [38]. We observed α-SMA positivity in 
only one case which was histopathologically diagnosed as undifferentiated sarcoma. 
In this case, vimentin and sarcomeric actin were also positive, thus the diagnosis was 
changed as hemangiopericytoma. In another case diagnosed as perivascular wall tumor 
in histopathology, vimentin and S100 positivities were seen. Due to some reports 
mentioning S100 positivity in peripheral wall tumors [17,32] and the observation of  
a whirling pattern in our case, the fi nal diagnosis was made as hemangiopericytoma.
Malignant fi brous histiocytoma is in the “fi brohistiocytic” category according to the 
2002 WHO Classifi cation [39]. In humans, malignant fi brous histiocytoma is classifi ed 
as storiform-pleomorphic, giant cell, infl ammatory, myxoid, and angiomatoid 
type according to the common cell type [40]. However, only three types have been 
reported in domestic animals [41] and these types were reclassifi ed as undifferentiated 
pleomorphic sarcoma in the new classifi cation [39]. In our study, CD3, CD18, CD20, 
CD204, E-cadherin, tryptase, and vimentin immunostaining was performed for the 
differentiation of  malignant fi brous histiocytoma from histiocytic sarcoma. Negativity 
of  CD3, CD18, CD20, E-cadherin, but positivity with CD204 and vimentin were 
observed. While canine histiocytic sarcomas are regularly CD18 positive and mostly 
vimentin negative, malignant fi brous histiocytomas have a vimentin positive and CD18 
negative phenotype [41-43]. Ko et al. [44] performed α-SMA, CD68, desmin, S100 and 
vimentin in three canine malignant fi brous histiocytomas and they observed positivity 
for vimentin, positivity in only giant cells for CD68, and negativity for α-SMA, desmin, 
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and S100. These researchers suggest that even only vimentin positivity without any 
other special markers is useful for the diagnosis of  malignant fi brous histiocytoma. 
Similarly, in our mentioned case, due to the negativity of  CD18 and positivity of  
vimentin and CD204, a diagnosis of  malignant fi brous histiocytoma was made.
In one study, the accuracy of  cytology in round cell tumors has been found to be less 
than 50% [10]. Ghisleni et al. [12] also reported that there were certain limitations in 
determining the origin and benignancy/malignancy of  10 round cell tumors. In our 
study, cytological diagnoses of  mastocytomas, and histiocytomas were confi rmed in all 
cases. Mastocytoma diagnosis is generally considered simple due to distinct cytoplasmic 
granules [8,45,46], and high accuracy rates between cytology and histopathology 
have been reported [12,14]. Although certain studies report high accuracy rates for 
cytological diagnosis of  histiocytomas [12,47], some histiocytic tumors cannot be 
differentiated from other round cell tumors (lymphoma, plasmacytoma) and only 
a round cell tumor diagnosis can be made with cytology [12,14,45]. Distinguishing 
histiocytic sarcoma from lymphoma and plasmacytoma can also be diffi cult [47]. 
In canine cutaneous round cell tumors, histopathology is generally not suffi cient 
for the exact diagnosis and immunohistochemical stainings should also be utilized 
[48]. CD18, E-cadherin, and MHC-II have been suggested as useful markers for the 
immunohistochemical diagnosis of  histiocytic tumors. Furthermore, CD3 and CD79 
have been suggested as markers for the differentiation of  B and T cell lymphomas 
[42,47,49]. Fernandez et al. [48] examined 72 canine cutaneous round cell tumors and 
used tryptase, chymase, and serotonin for mast cells; CD1a, CD18, and MHC-II for 
histiocytes; CD3 for T lymphocytes; and CD79a for B lymphocytes and plasma cells. 
We used only tryptase for mastocytomas; CD3, CD18, and CD20 for lymphomas; 
CD18, CD204, E-cadherin, and vimentin for histiocytic tumors. CD18 was used for 
differentiation of  malignant fi brous histiocytoma from histiocytic sarcoma. Tryptase 
positivity was deemed suffi cient in diagnosis of  mastocytomas, and no further 
immunohistochemical stainings were performed to keep costs low.
For differentiation of  canine lymphomas from other round cell tumors, 
immunohistochemical staining should be performed in many cases [49]. In our study, 
one lymphoma case revealed CD3 and CD18 positivity and the fi nal diagnosis was 
made as T cell lymphoma. In other case which was diagnosed as lymphoma, positivity 
of  CD18 and negativity of  CD3 and CD20 were observed. CD18 is a formalin-
resistant integrin molecule on the surface of  leukocytes and dendritic cells originating 
from bone marrow. For this reason, CD18 (or MHC-II) positive and CD3 or CD79a 
negative tumoral cells are considered as of  a histiocytic origin [42,43,47,50]. However, 
atypical immunophenotype of  tumor cells have also been reported rarely [51,52]. As 
an example null lymphomas do not express CD3 and CD79a or light and heavy chains 
of  immunoglobulins [53-55]. 
Null lymphoma has been rarely reported in dogs. This tumor has been suggested to 
have a “natural killer” cell origin [53]. CD3 and CD79a negativity of  these tumors does 
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not necessarily mean that these are not lymphoma. Granularity feature of  tumoral cells 
may be useful for diagnosis, but additional immunohistochemical staining may also 
be needed [56]. Therefore, we performed E-cadherin and tryptase in the case of  null-
lymphoma and these two markers were found negative. 
In our study CD18 was used for the determination of  leukocytic origin and all round 
cell tumors showed positivity. Unlike a previous report [21], we observed E-cadherin 
positivity in only one histiocytoma case, but not in other three histiocytomas. In 
dogs, E-cadherin is a marker used for histiocytomas [57,58], but not a specifi c marker 
for Langerhans cells [21]. Pazdzior-Czapula et al. [47] showed limited positivity for 
CD18, E-cadherin, and MHC-II expressions in canine cutaneous histiocytomas. 
They suggested that E-cadherin has limited value for the diagnosis of  cutaneous 
histiocytomas. According to Valli et al. [51], Langerhans cells are unique cells which 
express E-cadherin. However, according to some other studies, due to its expression in 
plasmacytomas and epitheliotropic lymphomas, E-cadherin is not considered a unique 
marker for Langerhans cells and it cannot be used for the exact differentiation of  
canine cutaneous round cell tumors [47,59].
It has been reported that canine histiocytic sarcomas express CD1, CD11c, CD18, 
CD45 and MHC-II but not express E-cadherin [18] and these tumors originated 
from dendritic cells [21,42]. In another study, because of  E-cadherin positivity in two 
histiocytic sarcomas, it was thought that Langerhans cell origin of  these tumors [47]. 
Hirako et al. [60] reported that primary cutaneous histiocytic sarcoma originated from 
Langerhans cells in a male Pembroke Welsh Corgi dog. They showed immunopositivity 
for vimentin, HLA-DR antigen, Iba1, CD18 and E-cadherin, thus they suggested 
Langerhans cell origin due to the E-cadherin positivity. In our study, E-cadherin 
positivity was observed in three histiocytic sarcomas. Furthermore, CD18, CD204 
and vimentin positivity were observed in same cases.
CONCLUSION
As a result of  our study, we suggest that cytopathology is a reliable and quick technique 
with high accuracy rate (84.5% for tumoral/non-tumoral comparison and 83% for 
comparison of  benignancy/malignancy) as compared to histopathology. The main 
diagnostic challenge in cytology is the mesenchymal tumor. Even histopathology 
is not suffi cient for the accurate diagnosis of  mesenchymal and round cell tumors, 
and specifi c immunohistochemical panels should be performed for accurate 
diagnosis. Furthermore, histopathology is the method that confi rms or refutes the 
cytopathological diagnosis, and also guides the immunohistochemistry in some cases. 
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UPOREDNO ISPITIVANJE CITOLOŠKIH, HISTOPATOLOŠKIH I 
IMUNOHISTOHEMIJSKIH METODA DIJAGNOSTIKE KUTANIH 
I SUPKUTANIH MASA KOD PASA
IPEK Volkan, CANGUL I.Taci, AKKOC Ahmet
U studiji je urađena uporedna analiza citoloških, histopatoloških i imunohistohemijskih 
dijagnostičkih metoda ispitivanja kutanih i supkutanih masa kod 71 pasa. Citološka 
dijagnoza je obuhvatala 56 tumora (21 mezenhimskog porekla, 15 epitelnih, 16 tumora 
okruglih ćelija i četiri melanocitna tumora), 13 infl amatornih promena i dve ciste. Od 
dvadesetjednog mezenhimskog  tumora, tri su kasnije potvrđena kao neneoplastične 
lezije, (hematomi, granulomatozno tkivo, fi broepitelijalni polip). Posle histopatoloških 
ispitivanja, trinaest od ukupno 15 epitelnih tumora, citološki su bili pravilno 
dijagnostikovani pri čemu su dva potvrđena kao neneoplastične tvorevine (fi broepitelni 
polip, granulaciono tkivo). Jedan mastocitom je kasnije potvrđen kao fi brozna 
hiperplazija. Dijagnoza je bila tačna u slučajevima tumora okruglih ćelija. Citološka 
dijagnoza je bila tačna u svim slučajevima melanotičnih tumora i cista. Pet slučajeva 
kod kojih je citološki nalaz ukazivao na zapaljenske reakcije, posle histopatološkog 
ispitivanja dijagnostikovani su kao tumori (limfom, papilom, sebaceozni adenom 
i skvamozni karcinom). Primenom imunohistohemijskih metoda, potvrđene su 
histopatološke dijagnoze svih epitelnih i tumora okruglih ćelija dok je dijagnoza šest 
mezenhimskih tumora promenjena posle ispitivanja imunohistohemijskim metodama. 
Tačnost citoloških ispitivanja u dijagnostici tumora i netumorskih tvorevina bila je 
84,5%, pri čemu je tačnost u određivanju benignog/malignog ponašanja tkiva bila 
83%. Usklađenost između histopatološkog i imunohistohemijskog rezultata bila je 
86,6%. Visok nivo tačnosti koji je dobijen na osnovu citoloških ispitivanja, dokazuje 
da je citološka metoda ispitivanja dobra početna dijagnostiča tehnika. Međutim i 
dalje je glavni izazov u dijagnostičkom smislu, ispitivanje mezenhimskih tumora kao 
i tumora praćenih infl amacijom. Rezultati ukazuju da imunohistohemijsko ispitivanje 
predstavlja osnovu dijagnoze većine mezenhimskih tumora.  
